Explain this page
Arphra AIPlain-English read on Albemarle Corporation’s valuationIncome statement
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Revenue & profit | |||||||||
| Revenue | $3.33B | $7.32B | $9.62B | $5.38B | $5.14B | $6.2B | $6.58B | $6.75B | $6.98B |
| Cost of revenue | $2.32B | $4.23B | $8.42B | $5.32B | $4.47B | $5.62B | $5.89B | $6.19B | $6.24B |
| Gross profit | $1.01B | $3.09B | $1.2B | $60.24M | $671.62M | $558.04M | $592.48M | $610.01M | $635.52M |
| Gross margin | +30.30% | +42.15% | +12.49% | +1.12% | +13.06% | +9.00% | +9.00% | +9.04% | +9.10% |
| Operating | |||||||||
| Research & development | $54.03M | $71.98M | $85.73M | $86.72M | $51.4M | $73.1M | $77.57M | $80.96M | $80.98M |
| Selling, general & administrative | $421.79M | $512.15M | $874.16M | $609.53M | $526.43M | $624.24M | $654.86M | $676.52M | $702.98M |
| Total operating expenses | $475.81M | $584.13M | $959.89M | $696.25M | $577.83M | $692.32M | $756.91M | $747.71M | $800.05M |
| Operating income | $532.66M | $2.5B | $241.12M | -$636.01M | $93.79M | -$159.43M | -$166.79M | -$170.87M | -$178.83M |
| Operating margin | +16.01% | +34.17% | +2.51% | -11.83% | +1.82% | -2.57% | -2.53% | -2.53% | -2.56% |
| EBITDA | $786.66M | $2.8B | $671.07M | -$45.07M | $754.37M | $435.7M | $469.81M | $481.57M | $471.16M |
| EBIT | $532.66M | $2.5B | $241.12M | -$636.01M | $93.79M | -$156.44M | -$164.5M | -$167.21M | -$174.78M |
| Below the line | |||||||||
| Interest expense | $61.48M | $122.97M | $116.07M | $165.62M | $207.65M | $176.46M | $177.83M | $184.18M | $193.92M |
| Interest income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other income / expense | -$303.27M | $704.26M | $1.86B | -$412.39M | -$402.12M | — | — | — | — |
| Pre-tax income | $229.39M | $3.21B | $2.1B | -$1.05B | -$308.33M | -$74.61M | -$79.24M | -$82.96M | -$85.22M |
| Income tax expense | $29.45M | $390.59M | $430.28M | $87.09M | $156.88M | -$15.01M | -$16.63M | -$16.66M | -$17.31M |
| Earnings | |||||||||
| Net income | $123.67M | $2.69B | $1.57B | -$1.18B | -$510.63M | -$326.14M | -$333.48M | -$344.87M | -$369.88M |
| Net income · continuing ops | $199.94M | $2.82B | $1.67B | -$1.14B | -$465.21M | -$267.04M | -$279.25M | -$288.03M | -$306.21M |
| Net margin | +3.72% | +36.75% | +16.36% | -21.93% | -9.93% | -5.26% | -5.07% | -5.11% | -5.30% |
| EPS · basic | $1.07 | $22.97 | $13.41 | $-11.20 | $-5.75 | $12.14 | $12.13 | $11.87 | $11.43 |
| EPS · diluted | $1.06 | $22.84 | $13.36 | $-11.20 | $-5.75 | $11.99 | $12.00 | $11.79 | $11.56 |
| EPS · low estimate | — | — | — | — | — | $8.57 | $7.35 | $7.76 | $9.91 |
| EPS · high estimate | — | — | — | — | — | $15.78 | $17.25 | $21.66 | $14.26 |
| Shares · basic | 115.84M | 117.12M | 117.32M | 117.52M | 117.7M | 117.35M | 116.65M | 118.16M | 117.08M |
| Shares · diluted | 116.54M | 117.79M | 117.77M | 117.52M | 117.7M | 118.14M | 117.96M | 116.85M | 118.65M |
| Coverage | |||||||||
| Analysts (revenue) | — | — | — | — | — | 15 | 14 | 11 | 5 |
| Analysts (EPS) | — | — | — | — | — | 11 | 11 | 4 | 2 |
Coverage notes. Historical figures come’s as-reported income statements / balance sheets / cash flows in our data warehouse. Forecast columns (italicised, faint accent tint) carry vendor-supplied numbers where available (revenue + EPS consensus) and ratio-derived values for every other line. Margins / ratios are the trailing-3y average from history applied to the forecast revenue; values are clamped to enforce P&L identity (gross ≥ operating, EBITDA ≥ operating, net ≤ operating) and balance-sheet identity (assets = liabilities + equity by construction). Cash-flow FCF reconciles to OCF + CapEx. USD conversion uses the period-end close of the issuer's reported/USD pair from forex_prices_daily; share counts stay unconverted.
Financials
Full income statement, balance sheet, and cash-flow history is included with Pro.
Upgrade to Pro